Atsushi Umemura
Research Subjects
Atsushi Umemura has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Hideyuki Sawada
Department of Neurology, Utano National Hospital, National Hospital Organization, Kyoto, Japan
18 shared publications Tomoko Oeda
Neurology, Department of Clinical Research, National Hospital Organization Utano National Hospital, Kyoto, Japan
17 shared publications- Kenji Yamamoto
Clinical Research Center and Department of Neurology, Utano National Hospital, Kyoto, Japan
13 shared publications Masayuki Kohsaka
Department of Neurology, Utano National Hospital, National Hospital Organization, Kyoto, Japan
13 shared publications- Satoshi Tomita
Department of Neurology and Clinical Research Center, National Hospital of Utano, National Hospital Organization, Kyoto, Japan
11 shared publications Kwiyoung Park
Neurology, Department of Clinical Research, National Hospital Organization Utano National Hospital, Kyoto, Japan
10 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (1) , e001497
Hallucinations and cognitive impairment are associated with blood pressure fluctuations in Parkinson’s disease
Background: Patients with Parkinson’s disease (PD) frequently develop cardiovascular autonomic dysfunctions, including blood pressure (BP) fluctuations and orthostatic hypotension (OH) in the early stage, and hallucinations or cognitive impairment in the middle stage to late stage. The current study aimed to determine whether OH, BP fluctuations and cerebral white matter hyperintensities (WMHs) on MRI are associated with the development of hallucinations and cognitive impairment. Methods: In this joint cross-sectional case–control study conducted across two institutions, we analysed the systolic BP coefficient of variation (SBP-CV) and nocturnal BP dipping using ambulatory BP monitoring and OH prevalence in 121 patients with PD and 21 hospital controls. The association between these factors and hallucinations/psychosis or cognitive impairment was analysed using multivariable logistic regression models. Then, we conducted mediation analyses of the relationship between abnormal BP fluctuations and cognitive impairment in PD, with WMHs evaluated using the Fazekas scale as the intermediate factor. Results: Patients with PD were characterised by large SBP-CV without pulse rate-CV elevation, neurogenic OH and riser pattern of nocturnal BP dipping. Neurogenic OH was significantly associated with hallucinations/psychosis (adjusted OR: 6.22; 95% CI 2.47 to 15.64; p<0.001), and large SBP-CV was significantly associated with hallucinations/psychosis (adjusted OR: 2.15; 95% CI 1.32 to 3.53/5 points; p=0.002) and cognitive impairment (adjusted OR: 1.79; 95% CI 1.15 to 2.78/5 points; p=0.010). Periventricular hyperintensity (PVH) was associated with cognitive impairment (adjusted OR: 5.80; 95% CI 1.81 to 18.61; p=0.003), but not with BP fluctuations. The ORs for SBP-CV in cognitive impairment in PD were very similar across multivariable analyses that included PVH or deep WMH as mediator variables. Conclusions: Large BP fluctuations in PD were associated with hallucinations and cognitive impairment, but WMHs did not mediate this relationship.
- 1 January 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (1) , e001497
Open AccessHallucinations and cognitive impairment are associated with blood pressure fluctuations in Parkinson’s disease
Background: Patients with Parkinson’s disease (PD) frequently develop cardiovascular autonomic dysfunctions, including blood pressure (BP) fluctuations and orthostatic hypotension (OH) in the early stage, and hallucinations or cognitive impairment in the middle stage to late stage. The current study aimed to determine whether OH, BP fluctuations and cerebral white matter hyperintensities (WMHs) on MRI are associated with the development of hallucinations and cognitive impairment. Methods: In this joint cross-sectional case–control study conducted across two institutions, we analysed the systolic BP coefficient of variation (SBP-CV) and nocturnal BP dipping using ambulatory BP monitoring and OH prevalence in 121 patients with PD and 21 hospital controls. The association between these factors and hallucinations/psychosis or cognitive impairment was analysed using multivariable logistic regression models. Then, we conducted mediation analyses of the relationship between abnormal BP fluctuations and cognitive impairment in PD, with WMHs evaluated using the Fazekas scale as the intermediate factor. Results: Patients with PD were characterised by large SBP-CV without pulse rate-CV elevation, neurogenic OH and riser pattern of nocturnal BP dipping. Neurogenic OH was significantly associated with hallucinations/psychosis (adjusted OR: 6.22; 95% CI 2.47 to 15.64; p<0.001), and large SBP-CV was significantly associated with hallucinations/psychosis (adjusted OR: 2.15; 95% CI 1.32 to 3.53/5 points; p=0.002) and cognitive impairment (adjusted OR: 1.79; 95% CI 1.15 to 2.78/5 points; p=0.010). Periventricular hyperintensity (PVH) was associated with cognitive impairment (adjusted OR: 5.80; 95% CI 1.81 to 18.61; p=0.003), but not with BP fluctuations. The ORs for SBP-CV in cognitive impairment in PD were very similar across multivariable analyses that included PVH or deep WMH as mediator variables. Conclusions: Large BP fluctuations in PD were associated with hallucinations and cognitive impairment, but WMHs did not mediate this relationship.
- 16 February 2022
- Published by Wiley in Electrical Engineering in Japan
- Vol. 215 (1) , e23362
Stability improvement of power system by cooperative virtual inertia control and reactive power control of PMSG wind generator and battery
Renewable energy generation systems are promising energy sources; however, they have a problem that they do not have, in general, inertia and synchronous power. A system with low inertial and synchronization forces has low stabilizing capability, and such systems are vulnerable to network fault and can cause large frequency fluctuations. This paper focuses on a large storage battery and a permanent magnet synchronous generator (PMSG) based variable‐speed wind power generator, and a new cooperative virtual inertia and reactive power control system between them which is based on Fuzzy Logic controller (FLC) and asymmetric hysteresis deadband is proposed and designed. Its effectiveness on the system stability enhancement during a grid fault is confirmed by simulation analyses on PSCAD/EMTDC.
- 16 February 2022
- Published by Wiley in Electrical Engineering in Japan
- Vol. 215 (1) , e23362
Stability improvement of power system by cooperative virtual inertia control and reactive power control of PMSG wind generator and battery
Renewable energy generation systems are promising energy sources; however, they have a problem that they do not have, in general, inertia and synchronous power. A system with low inertial and synchronization forces has low stabilizing capability, and such systems are vulnerable to network fault and can cause large frequency fluctuations. This paper focuses on a large storage battery and a permanent magnet synchronous generator (PMSG) based variable‐speed wind power generator, and a new cooperative virtual inertia and reactive power control system between them which is based on Fuzzy Logic controller (FLC) and asymmetric hysteresis deadband is proposed and designed. Its effectiveness on the system stability enhancement during a grid fault is confirmed by simulation analyses on PSCAD/EMTDC.
- 7 December 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 101-106
Cooperative Virtual Inertia and Reactive Power Control of PMSG Wind Generator and Battery for Improving Transient Stability of Power System
Renewable energy sources are a promising future power source. However, many of the renewable energy power sources such as solar and wind power are connected to the power grid through inverters. Such power sources controlled with an inverter have almost no inertia and synchronization power. Therefore, as the amount of the renewable energy power sources increases, conventional synchronous generators need to be disconnected, and thus, the inertial and synchronization powers of the system decrease. Such systems are vulnerable to network fault and can have large frequency fluctuations. In this paper, virtual inertia control and reactive power control are applied to a variable speed wind turbines with permanent magnet synchronous generator (VSWT-PMSG) based wind farm and storage battery connected to the grid. The reactive power control is activated after a ground fault accident to prevent fixed speed wind turbines with squirrel cage induction generator (FSWT-SCIG) based wind farm from becoming unstable and disconnected. Then the virtual inertia control (active power control) is activated when the system frequency fluctuations become large due to the FSWT-SCIG based wind farm disconnection. Effectiveness of the proposed method on the transient stability improvement during a grid fault is evaluated by simulation analyses on PSCAD/EMTDC.
- 7 December 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 101-106
Cooperative Virtual Inertia and Reactive Power Control of PMSG Wind Generator and Battery for Improving Transient Stability of Power System
Renewable energy sources are a promising future power source. However, many of the renewable energy power sources such as solar and wind power are connected to the power grid through inverters. Such power sources controlled with an inverter have almost no inertia and synchronization power. Therefore, as the amount of the renewable energy power sources increases, conventional synchronous generators need to be disconnected, and thus, the inertial and synchronization powers of the system decrease. Such systems are vulnerable to network fault and can have large frequency fluctuations. In this paper, virtual inertia control and reactive power control are applied to a variable speed wind turbines with permanent magnet synchronous generator (VSWT-PMSG) based wind farm and storage battery connected to the grid. The reactive power control is activated after a ground fault accident to prevent fixed speed wind turbines with squirrel cage induction generator (FSWT-SCIG) based wind farm from becoming unstable and disconnected. Then the virtual inertia control (active power control) is activated when the system frequency fluctuations become large due to the FSWT-SCIG based wind farm disconnection. Effectiveness of the proposed method on the transient stability improvement during a grid fault is evaluated by simulation analyses on PSCAD/EMTDC.
- 31 August 2020
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 22 (3) , 363-371
Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial
Cholinergic neurotransmission regulates neuroinflammation in Parkinson disease (PD). The authors conducted a delayed-start study of donepezil for cognitive decline in non-demented PD patients. The ...
- 31 August 2020
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 22 (3) , 363-371
Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial
Cholinergic neurotransmission regulates neuroinflammation in Parkinson disease (PD). The authors conducted a delayed-start study of donepezil for cognitive decline in non-demented PD patients. The ...
- Top Cited Papers
- 1 April 2020
- Published by Elsevier in The Lancet Neurology
- Vol. 19 (4) , 298-306
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
- 1 April 2020
- Published by Elsevier in The Lancet Neurology
- Vol. 19 (4) , 298-306
Top Cited PapersSafety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
- Open Access
- 31 January 2020
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 13 (1) , 57-61
Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
The long-term efficacy of deep brain stimulation (DBS) for motor fluctuations in advanced Parkinson's disease (PD) has been well established; however, motor fluctuations may recur over time despite multiple adjustments of DBS settings and medications. We conducted a retrospective chart review of three patients for whom levodopa-carbidopa intestinal gel (LCIG) was additionally administered as a rescue therapy for secondary DBS failure due to the recurrence of motor fluctuations. The three patients had advanced PD with a disease duration of 14-19 years, and had undergone DBS for motor fluctuations refractory to standard medical management. LCIG was administered to the patients because of symptom recurrence years after DBS and provided complementary effects in all patients. The cases presented here show that rescue LCIG therapy may be a complementary treatment option for patients with post-DBS advanced PD who have a recurrence of troublesome motor complications.
- 31 January 2020
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 13 (1) , 57-61
Open AccessRescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
The long-term efficacy of deep brain stimulation (DBS) for motor fluctuations in advanced Parkinson's disease (PD) has been well established; however, motor fluctuations may recur over time despite multiple adjustments of DBS settings and medications. We conducted a retrospective chart review of three patients for whom levodopa-carbidopa intestinal gel (LCIG) was additionally administered as a rescue therapy for secondary DBS failure due to the recurrence of motor fluctuations. The three patients had advanced PD with a disease duration of 14-19 years, and had undergone DBS for motor fluctuations refractory to standard medical management. LCIG was administered to the patients because of symptom recurrence years after DBS and provided complementary effects in all patients. The cases presented here show that rescue LCIG therapy may be a complementary treatment option for patients with post-DBS advanced PD who have a recurrence of troublesome motor complications.
- 1 December 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Stabilization Control of Power System with Large-Scale Wind Farm by HVDC Interconnection Line
Renewable energy such as wind energy has attracted special interest from the viewpoint of stability of energy supply nowadays. However, power system including large-scale wind farm (WF) can become unstable during a fault condition because of the instantaneous voltage drop and frequency fluctuations when WF is decoupled in accordance with the grid code of Fault Ride Through (FRT) requirement. This paper presents a new control strategy by High Voltage Direct Current (HVDC) transmission line. The proposed system controls active power and reactive power delivered to the grid from HVDC line during a fault condition. The effectiveness of the proposed method is confirmed by simulation analyses.
- 1 December 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Stabilization Control of Power System with Large-Scale Wind Farm by HVDC Interconnection Line
Renewable energy such as wind energy has attracted special interest from the viewpoint of stability of energy supply nowadays. However, power system including large-scale wind farm (WF) can become unstable during a fault condition because of the instantaneous voltage drop and frequency fluctuations when WF is decoupled in accordance with the grid code of Fault Ride Through (FRT) requirement. This paper presents a new control strategy by High Voltage Direct Current (HVDC) transmission line. The proposed system controls active power and reactive power delivered to the grid from HVDC line during a fault condition. The effectiveness of the proposed method is confirmed by simulation analyses.
- 1 December 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Transient Stability Enhancement of Power System Including Large-Scale Wind Farm by the Coordinated Control of Adjustable-Speed Pumped-Storage Generator and Battery
Nowadays penetration level of wind farm (WF) into the power system has increased rapidly. However, the increasing penetration can lead to the power system instability during network disturbance and the power system may become unstable. A novel frequency control strategy using adjustable speed pumped storage generators (ASG) and battery is proposed in this paper to enhance the entire system transient stability during a trip of fixed speed wind turbines using squirrel cage induction generators (FSWT-SCIGs) based WF due to a severe short circuit fault. The proposed control strategy has been evaluated by simulation analysis on a model system composed of conventional synchronous generators (SGs), ASG, battery, and SCIG-based WF. Obtained results clearly show that the presented control method can effectively prevent the instability of the model system.
- 1 December 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Transient Stability Enhancement of Power System Including Large-Scale Wind Farm by the Coordinated Control of Adjustable-Speed Pumped-Storage Generator and Battery
Nowadays penetration level of wind farm (WF) into the power system has increased rapidly. However, the increasing penetration can lead to the power system instability during network disturbance and the power system may become unstable. A novel frequency control strategy using adjustable speed pumped storage generators (ASG) and battery is proposed in this paper to enhance the entire system transient stability during a trip of fixed speed wind turbines using squirrel cage induction generators (FSWT-SCIGs) based WF due to a severe short circuit fault. The proposed control strategy has been evaluated by simulation analysis on a model system composed of conventional synchronous generators (SGs), ASG, battery, and SCIG-based WF. Obtained results clearly show that the presented control method can effectively prevent the instability of the model system.
- 1 October 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 55, 81-85
Low body mass index and life prognosis in Parkinson's disease
- 1 October 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 55, 81-85
Low body mass index and life prognosis in Parkinson's disease
- Open Access
- 3 August 2018
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 89 (12) , 1332-1340
Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years
Objectives Brain acetylcholine is decreased even in patients with cognitively preserved Parkinson’s disease (PD). We investigated whether early and long-term use of donepezil prevents psychosis in non-demented PD patients. Methods A double-blinded, placebo-controlled trial was conducted. A total of 145 non-demented PD patients were randomly assigned to receive 5 mg/day donepezil (n=72) or placebo (n=73) for 96 weeks. Medications for PD were not restricted, but antipsychotic drugs were not permitted throughout the study. The primary outcome measure was survival time to psychosis that was predefined by Parkinson’s Psychosis Questionnaire (PPQ) B score ≥2 or C score ≥2. Secondary outcome measures included psychosis developing within 48 weeks, total PPQ score, Mini-Mental State Examination (MMSE), Wechsler Memory Scale (WMS) and subgroup analysis by apolipoprotein ε4 genotyping. Results Kaplan-Meier curves for psychosis development were very similar between the two groups, and the Cox proportional hazard model revealed an adjusted HR of 0.87 (95%CI 0.48 to 1.60). The changes in MMSE and WMS-1 (auditory memory) were significantly better with donepezil than in placebo. In the subgroup analysis, donepezil provided an HR of 0.31 (0.11–0.86) against psychosis in 48 weeks for apolipoprotein ε4 non-carriers. Conclusions Although donepezil provided beneficial effects on PPQ, MMSE and auditory WMS score changes in 2 years, it had no prophylactic effect on development of psychosis in PD. Apolipoprotein ε4 may suppress the antipsychotic effect of donepezil. Trial registration number UMIN000005403.
- 3 August 2018
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 89 (12) , 1332-1340
Open AccessEarly use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years
Objectives Brain acetylcholine is decreased even in patients with cognitively preserved Parkinson’s disease (PD). We investigated whether early and long-term use of donepezil prevents psychosis in non-demented PD patients. Methods A double-blinded, placebo-controlled trial was conducted. A total of 145 non-demented PD patients were randomly assigned to receive 5 mg/day donepezil (n=72) or placebo (n=73) for 96 weeks. Medications for PD were not restricted, but antipsychotic drugs were not permitted throughout the study. The primary outcome measure was survival time to psychosis that was predefined by Parkinson’s Psychosis Questionnaire (PPQ) B score ≥2 or C score ≥2. Secondary outcome measures included psychosis developing within 48 weeks, total PPQ score, Mini-Mental State Examination (MMSE), Wechsler Memory Scale (WMS) and subgroup analysis by apolipoprotein ε4 genotyping. Results Kaplan-Meier curves for psychosis development were very similar between the two groups, and the Cox proportional hazard model revealed an adjusted HR of 0.87 (95%CI 0.48 to 1.60). The changes in MMSE and WMS-1 (auditory memory) were significantly better with donepezil than in placebo. In the subgroup analysis, donepezil provided an HR of 0.31 (0.11–0.86) against psychosis in 48 weeks for apolipoprotein ε4 non-carriers. Conclusions Although donepezil provided beneficial effects on PPQ, MMSE and auditory WMS score changes in 2 years, it had no prophylactic effect on development of psychosis in PD. Apolipoprotein ε4 may suppress the antipsychotic effect of donepezil. Trial registration number UMIN000005403.